Director/PDMR Shareholding

RNS Number : 0210T
Bellevue Healthcare Trust PLC
19 July 2022
 

Bellevue Healthcare Trust plc

Directors Dealings

Bellevue Healthcare Trust plc announces that the undermentioned directors of the Company on 14 July 2022 sold and following settlement, repurchased Ordinary Shares through a Bed and ISA arrangement, in order to effect the transfer of the Ordinary Shares to their respective ISA accounts.

The transactions are summarised below:

 Director

Shares sold

Shares acquired

Total holding following notification

% of current issued Ordinary Share capital

Jo Dixon

10,344

10,344

94,833

0.0162%

Kate Bolsover

6,245

6,142

11,248

0.0019%

 

The notification can be found below. This announcement is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Jo Dixon

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Bellevue Healthcare Trust plc

b)

 

LEI

 

 

 

213800HQ3J3H9YF2UI82

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares



Identification code

ISIN

GB00BZCNLL95



b)

 

Nature of the transaction

 

 

Sale of 10,344 Ordinary Shares and repurchase of 10,344 Ordinary Shares

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)


Transaction 1 (sale)


160.5800p per share

10,344


Transaction 2 (purchase)


165.6319p per share

10,344







d)

 

Aggregated information




- Aggregated volume

Sale: 10,344

Purchase: 10,344



- Price

Total price sale: £16,610.40

Total price purchase: £17,132.96

 



e)

 

Date of the transaction

 

 

14 July 2022 (Transaction 1)

18 July 2022 (Transaction 2)

f)

 

Place of the transaction

 

 

London Stock Exchange

 

 

 

 

 

 

 

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Kate Bolsover

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Bellevue Healthcare Trust plc

b)

 

LEI

 

 

 

213800HQ3J3H9YF2UI82

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares



Identification code

ISIN

GB00BZCNLL95



b)

 

Nature of the transaction

 

 

Sale of 6,245 Ordinary Shares and repurchase of 6,142 Ordinary Shares

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)


Transaction 1 (sale)


157.92p per share

6,245


Transaction 2 (purchase)


161.00p per share

6,142







d)

 

Aggregated information




- Aggregated volume

Sale: 6,245

Purchase: 6,142



- Price

Total price sale: £9,862.10

Total price purchase: £9,888.62

 



e)

 

Date of the transaction

 

 

14 July 2022 (Transaction 1)

19 July 2022 (Transaction 2)

f)

 

Place of the transaction

 

 

London Stock Exchange

 

Enquiries:

 

Ciara McKillop

020 3327 9720

Sanne Fund Services (UK) Limited


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHZKLFFLDLFBBF
UK 100

Latest directors dealings